Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Mirum Pharmaceuticals (MIRM) Cost of Revenue (2023 - 2025)

Mirum Pharmaceuticals has reported Cost of Revenue over the past 3 years, most recently at $28.3 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $28.3 million for Q4 2025, up 24.07% from a year ago — trailing twelve months through Dec 2025 was $100.2 million (up 22.78% YoY), and the annual figure for FY2025 was $100.2 million, up 22.78%.
  • Cost of Revenue for Q4 2025 was $28.3 million at Mirum Pharmaceuticals, up from $25.5 million in the prior quarter.
  • Over the last five years, Cost of Revenue for MIRM hit a ceiling of $28.3 million in Q4 2025 and a floor of $5.0 million in Q1 2023.
  • Median Cost of Revenue over the past 3 years was $21.8 million (2024), compared with a mean of $19.1 million.
  • Peak annual rise in Cost of Revenue hit 258.1% in 2024, while the deepest fall reached 8.95% in 2024.
  • Mirum Pharmaceuticals' Cost of Revenue stood at $25.0 million in 2023, then dropped by 8.95% to $22.8 million in 2024, then increased by 24.07% to $28.3 million in 2025.
  • The last three reported values for Cost of Revenue were $28.3 million (Q4 2025), $25.5 million (Q3 2025), and $23.4 million (Q2 2025) per Business Quant data.